Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Graphite Bio Inc (NQ: GRPH ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Mar 21, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Graphite Bio Inc < Previous 1 2 3 4 5 Next > 12 Health Care Stocks Moving In Friday's Intraday Session January 06, 2023 Via Benzinga Nasdaq Gains 1.5%; Fate Therapeutics Shares Plunge January 06, 2023 U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 550 points on Friday. Via Benzinga Stocks That Hit 52-Week Lows On Friday January 06, 2023 During Friday's trading, 71 companies set new 52-week lows. Via Benzinga Graphite Bio Shares Tank After Pausing Sickle Cell Therapy Study January 06, 2023 Via Benzinga BMO Capital Sees Over 400% Upside For This Small Gene-Editing Stock June 17, 2022 Via Benzinga Dow Rises Over 300 Points; US Adds 223,000 Jobs In December January 06, 2023 U.S. stocks traded higher this morning, with the Dow Jones gaining more than 300 points on Friday. Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For January 6, 2023 January 06, 2023 Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session January 06, 2023 Via Benzinga Amarin To Rally 138%? Here Are 10 Other Analyst Forecasts For Friday January 06, 2023 Via Benzinga Why Graphite Bio Shares Are Trading Lower By 50%; Here Are 20 Stocks Moving Premarket January 06, 2023 Gainers OncoCyte Corporation (NASDAQ: OCX) rose 89.2% to $0.70 in pre-market trading. Oncocyte, last month, announced an over 40% reduction of its workforce to realign the team towards key products... Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday January 06, 2023 The final day of trading this week is here and we're starting it off with a look at the biggest pre-market stock movers for Friday! Via InvestorPlace Graphite Bio Announces Voluntary Pause of Phase 1/2 CEDAR Study of nulabeglogene autogedtemcel (nula-cel) for Sickle Cell Disease January 05, 2023 From Graphite Bio, Inc. Via Business Wire Graphite Bio Presents Preclinical Data for Novel Sequencing Method Used to Determine Gene Editing Outcomes at 64th ASH Annual Meeting December 11, 2022 From Graphite Bio, Inc. Via Business Wire Graphite Bio Announces Participation in Evercore ISI 5th Annual HealthCONx Conference November 21, 2022 From Graphite Bio, Inc. Via Business Wire Graphite Bio Reports Recent Business Progress and Third Quarter 2022 Financial Results November 09, 2022 From Graphite Bio, Inc. Via Business Wire Graphite Bio Announces Abstracts Accepted for Upcoming 64th ASH Annual Meeting and Exposition November 03, 2022 From Graphite Bio, Inc. Via Business Wire CRISPR Stocks: Will Concerns Over Risk Inhibit Gene-Editing Cures? October 20, 2022 Despite enthusiasm in some camps, the risk of potential cures clouds market projections. Via Investor's Business Daily Graphite Bio Announces Participation in 50th Annual Sickle Cell Disease Association of America National Convention October 11, 2022 From Graphite Bio, Inc. Via Business Wire 5 Value Stocks To Watch In The Healthcare Sector September 26, 2022 What is a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For September 15, 2022 September 15, 2022 Upgrades Via Benzinga Graphite Bio Announces Participation in Morgan Stanley 20th Annual Global Healthcare Conference September 06, 2022 From Graphite Bio, Inc. Via Business Wire 5 Value Stocks In The Healthcare Sector August 22, 2022 What is a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators... Via Benzinga Recap Of Thursday's Biotech Catalysts - End Of the Day Summary August 11, 2022 Via Benzinga Graphite Bio Reports Recent Business Progress and Second Quarter 2022 Financial Results August 11, 2022 From Graphite Bio, Inc. Via Business Wire Graphite Bio Shares Soar As Initial-Stage Blood Cell Disorder Study Launched August 11, 2022 Graphite Bio (NASDAQ: GRPH) announced the initiation of patient dosing in the Phase 1/2 CEDAR trial with its asset GPH101 (nulabeglogene autogedtemcel) in people with sickle cell disease (SCD). Via Benzinga Graphite Bio Doses First Patient with Investigational Gene Editing Therapy GPH101 for Sickle Cell Disease August 11, 2022 From Graphite Bio, Inc. Via Business Wire Graphite Bio Announces Participation in Jefferies Healthcare Conference June 01, 2022 From Graphite Bio, Inc. Via Business Wire Graphite Bio, Inc. (NASDAQ:GRPH) Investor Alert: Investigation over Potential Wrongdoing May 26, 2022 San Diego, CA -- (SBWIRE) -- 05/26/2022 -- An investigation on behalf of current long-term investors in shares of Graphite Bio, Inc. (NASDAQ:GRPH) was announced over potential breaches of fiduciary... Via SBWire Graphite Bio Presents Preclinical Gene Replacement Data for GPH102 for Beta-thalassemia at the ASGCT 25th Annual Meeting May 16, 2022 From Graphite Bio, Inc. Via Business Wire 110 Biggest Movers From Friday May 16, 2022 Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 154.9% to close at $0.51. ShiftPixy reported board approval special dividend to shareholders in form of common shares of Industrial Human Capital. Via Benzinga < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.